VistaGen Therapeutics Inc. | Ownership
Companies that own VistaGen Therapeutics Inc.
Sphera Funds Management Ltd.
1,371,892
5.31%
124,641
0.28%
06/30/2018
Empery Asset Management LP
945,220
3.66%
227,553
1.68%
12/31/2017
Heights Capital Management, Inc.
821,154
3.18%
821,154
0.04%
12/31/2017
Platinum Management (NY) LLC
346,431
1.34%
-385,489
1.85%
07/20/2018
The Vanguard Group, Inc.
180,375
0.7%
5,230
0%
06/30/2018
Geode Capital Management LLC
136,736
0.53%
106,639
0%
06/30/2018
KMS Financial Services, Inc.
104,414
0.4%
0
0.01%
06/30/2018
D.A. Davidson & Co. (Investment Management)
76,500
0.3%
23,000
0%
06/30/2018
G1 Execution Services LLC
72,467
0.28%
72,467
0.01%
06/30/2018
Berson & Corrado Investment Advisors LLC
45,428
0.18%
-21,000
0.02%
06/30/2018
| Address |
343 Allerton Avenue
South San Francisco California 94080
United States
|
|
Employees
|
- |
| Website |
http://www.vistagen.com |
| Updated |
07/08/2019 |
| VistaGen Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of new generation medicines for depression and other diseases and disorders of the central nervous system. It focuses on AV-101 product, an oral, non-opioid and non-sedating therapy that offers the potential to be a new at-home treatment for multiple central nervous system indications with high-unmet medical need. The company was founded by H. |
